about
Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics.Chronic Autoimmune Epithelitis in Sjögren's Syndrome and Primary Biliary Cholangitis: A Comprehensive Review.[Modern treatment of primary biliary cholangitis].Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis.Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Proposed therapies in primary biliary cholangitis.
@en
Proposed therapies in primary biliary cholangitis.
@nl
type
label
Proposed therapies in primary biliary cholangitis.
@en
Proposed therapies in primary biliary cholangitis.
@nl
prefLabel
Proposed therapies in primary biliary cholangitis.
@en
Proposed therapies in primary biliary cholangitis.
@nl
P2093
P2860
P1476
Proposed therapies in primary biliary cholangitis.
@en
P2093
Annarosa Floreani
Christopher L Bowlus
Nora Cazzagon
Zheng Sheng Zou
P2860
P304
P356
10.1586/17474124.2016.1121810
P577
2015-11-17T00:00:00Z